Survival-Inferred Fragility Index of Phase 3 Clinical Trials Evaluating Immune Checkpoint Inhibitors

IMPORTANCE: In science and medical research, extreme and dichotomous conclusions may be drawn based on whether the P value falls above or below the threshold. The fragility index (ie, the minimum number of changes from nonevents to events resulting in loss of statistical significance) captures the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Bomze, David, Asher, Nethanel, Hasan Ali, Omar, Flatz, Lukas, Azoulay, Daniel, Markel, Gal, Meirson, Tomer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584930/
https://www.ncbi.nlm.nih.gov/pubmed/33095247
http://dx.doi.org/10.1001/jamanetworkopen.2020.17675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584930/
https://www.ncbi.nlm.nih.gov/pubmed/33095247
http://dx.doi.org/10.1001/jamanetworkopen.2020.17675

Ejemplares similares